Quick Answer
ENANTA PHARMACEUTICALS INC reported Earnings Per Share Diluted of $3.84 (loss) per share for the year ending 2025.
- ENANTA PHARMACEUTICALS INC showed an increase of +29.9% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from ENANTA PHARMACEUTICALS INC's annual report (Form 10-K), filed with the SEC on November 19, 2025.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 15 years of available data (2011 to 2025), ENANTA PHARMACEUTICALS INC's Earnings Per Share Diluted has declined by 390.9%.
- Historical annual values: Fiscal year 2025: $3.84 (loss) per share | Fiscal year 2024: $5.48 (loss) per share | Fiscal year 2023: $6.38 (loss) per share | Fiscal year 2022: $5.91 (loss) per share | Fiscal year 2021: $3.92 (loss) per share | Fiscal year 2020: $1.81 (loss) per share | Fiscal year 2019: $2.21 per share | Fiscal year 2018: $3.48 per share | Fiscal year 2017: $0.91 per share | Fiscal year 2016: $1.13 per share | Fiscal year 2015: $4.09 per share | Fiscal year 2014: $1.80 per share | Fiscal year 2013: $0.67 (loss) per share | Fiscal year 2012: $1.13 per share | Fiscal year 2011: $1.32 per share.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: